Showing results (51-60 of 225) with videos related to
Sort By:
Pageof 23
Diabetes Care|August 27, 2024
Regional Heterogeneity of the Results of Glucagon-Like Peptide 1 Receptor Agonist Trials in Type 2 Diabetes: A Reanalysis of Individual Participant DataAriane Jullien, Clément Jambon-Barbara, Jean-Luc Cracowski, et al.Journal of Clinical Epidemiology|June 29, 2021
High prevalence of spin was found in pharmacovigilance studies using disproportionality analyses to detect safety signals: a meta-epidemiological studyAmelle Mouffak, Marion Lepelley, Bruno Revol, et al.Journal of Clinical Epidemiology|July 30, 2021
A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databasesCharles Khouri, Bruno Revol, Marion Lepelley, et al.Chemistry and Physics of Lipids|March 24, 2004
Isoprostanes: an emerging role in vascular physiology and disease?Jean-Luc CracowskiThe European Respiratory Journal|March 9, 2019
Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance-pharmacodynamic studyLucie Cornet, Charles Khouri, Matthieu Roustit, et al.Plos One|July 19, 2012
Iontophoresis of endothelin receptor antagonists in rats and menMatthieu Roustit, Sophie Blaise, Claire Arnaud, et al.The Lancet. Rheumatology|January 17, 2024
Comparative efficacy and safety of treatments for secondary Raynaud's phenomenon: a systematic review and network meta-analysis of randomised trialsCharles Khouri, Marion Lepelley, Sebastien Bailly, et al.Fundamental & Clinical Pharmacology|September 14, 2006
Cardiovascular pharmacology and physiology of the isoprostanesJean-Luc Cracowski, Thierry DurandMicrocirculation (New York, N.Y. : 1994)|February 2, 2012
Spotlight issue: Microcirculation—from a clinical perspectiveGeraldine Clough, Jean-Luc CracowskiThe American Journal of Cardiology|August 28, 2012
The potential of biomarkers in pulmonary arterial hypertensionJean-Luc Cracowski, Hanno H LeuchtePageof 23